Susanne X. Wang

Predictive validity of biochemical biomarkers in knee osteoarthritis: data from the FNIH OA Biomarkers Consortium

Virginia B. Kraus, Jamie E. Collins, David Hargrove et al. · Annals of the Rheumatic Diseases · 2016 · 277 citations · Full text

A randomized placebo-controlled phase 3 trial of an antisense oligonucleotide, drisapersen, in Duchenne muscular dystrophy

Nathalie Goemans, Eugenio Mercuri, Hirofumi Komaki et al. · Neuromuscular Disorders · 2017 · 119 citations · Full text

Duchenne Muscular Dystrophy, Medicine, Clinical Trials +5

The effects of glucosamine hydrochloride on subchondral bone changes in an animal model of osteoarthritis

Susanne X. Wang, Sheila Laverty, Mircea Dumitriu et al. · Arthritis & Rheumatism · 2007 · 90 citations

Healthcare resource utilization and costs by age and joint location among osteoarthritis patients in a privately insured population

Susanne X. Wang, Arijit Ganguli, Amit Bodhani et al. · Journal of Medical Economics · 2017 · 37 citations

Pharmacokinetics and Tolerability of a Dual Variable Domain Immunoglobulin ABT‐981 Against IL‐1α and IL‐1β in Healthy Subjects and Patients With Osteoarthritis of the Knee

Matthew P. Kosloski, Sandra Goss, Susanne X. Wang et al. · The Journal of Clinical Pharmacology · 2016 · 29 citations